Olivier Ethgen

PRM170 Optimizing Public Health Decision Over Time: A Dynamic Budget Optimization Model With Multiple Criteria Decision Making

Baudouin Standaert, Mark P. Connolly, Olivier Ethgen, 2012 .

CO4 Cost-Effectiveness Analysis - Appropriate for All Situations?

Baudouin Standaert, Olivier Ethgen, R. A. Emerson, 2012 .

Health-related quality of life in total hip and total knee arthroplasty. A qualitative and systematic review of the literature.

Olivier Ethgen, Florent Richy, Jean-Yves Reginster, 2004, The Journal of bone and joint surgery. American volume.

PHP100 Defining Elements of Value for Rare Disease Treatments

Olivier Ethgen, Pierrick Rollet, Claude Schmitt, 2012 .

Balancing benefits and risks of glucocorticoids in rheumatic diseases and other inflammatory joint disorders: new insights from emerging data. An expert consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)

Jean-Pierre Devogelaer, Patrick Emonts, René Rizzoli, 2016, Aging Clinical and Experimental Research.

The health economics burden of sarcopenia: a systematic review.

Olivier Ethgen, Jean-Yves Reginster, Charlotte Beaudart, 2019, Maturitas.

PHP102 From Value to Price: What Should Be the Path for Orphan Drugs?

Baudouin Standaert, Olivier Ethgen, Pierrick Rollet, 2012 .

Do utility values and willingness to pay suitably reflect health outcome in hip and knee osteoarthritis? A comparative analysis with the WOMAC Index.

Olivier Ethgen, Jean-Yves Reginster, Eric Lejeune, 2003, The Journal of rheumatology.

Can New Information and Communication Technologies Help in the Management of Osteoporosis?

Olivier Ethgen, Jean-Yves Reginster, Geoffrey Appelboom, 2014, Women's health.

Biochemical markers of bone and cartilage remodeling in prediction of longterm progression of knee osteoarthritis.

Olivier Ethgen, J. Reginster, O. Bruyère, 2003, The Journal of rheumatology.